Bladder cancer
Managing adverse events of systemic therapies in muscle-invasive and metastatic UCaDenis (77 years old)
77-year-old Denis worked as a judge for his whole life. Now he spends his days writing a memoir of his most memorable cases.
He is diagnosed with metastatic UCa of bladder.
Assessment summary:
- Medical history:
- Type 2 diabetes mellitus, previously poorly controlled (HbA1c 9.5%), currently improved under endocrinology follow-up
- Hypertension
- CT scan of chest, abdomen and pelvis: diffuse liver and bone metastases, biopsy compatible with UCa
- ECOG PS: 1
- No peripheral neuropathy
- No hearing impairment
- GFR: 40 ml/min
The patient completed 4 cycles of gemcitabine + carboplatin and achieved stable disease. Maintenance with avelumab was initiated. After 5 cycles of avelumab, imaging demonstrated a partial response, with marked regression of liver metastases and 4 residual bone lesions remaining.
At this time, he developed watery diarrhoea, abdominal cramping, urgency, and abdominal pain. Stool evaluation excluded an infectious cause. A diagnosis of grade 2 immune-mediated colitis was made.